Dark | Light
# Arrowhead Research Corporation (ARWR)

Arrowhead Pharmaceuticals (ARWR) stock is surging, hitting a 52-week high driven by positive FDA designations and a Novartis collaboration. Increased social media buzz and analyst price target hikes are fueling this upward momentum.

### About Arrowhead Research Corporation
Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing gene-silencing medicines for intractable diseases.  
Arrowhead Research Corporation uses the ticker $ARWR for trading. Listed in the [Stocks](/list/stocks) category within the [Healthcare](/list/stocks/healthcare) sectors.

### Insights
- Arrowhead Research Corporation (ARWR) social dominance hit [------] which is 103% higher than it's daily average.
- Arrowhead Research Corporation (ARWR) social dominance is up 210.22% from the previous [--] months.

### Price: $63.80
![Price Line Chart](https://lunarcrush.com/gi/w:600/t:$arwr/c:line/m:close/iv:1d.svg)  
[Price 24-Hour Time-Series Raw Data](/topic/$arwr/time-series/close.tsv)  
The stock price is strongly positive, reaching a 52-week high, supported by recent positive news like FDA Breakthrough Therapy Designation and a Novartis collaboration. Increased social media mentions and trading volume, along with a raised price target from Piper Sandler, are amplifying this upward momentum.  

24-Hour: 1.81%
7-Day: -1.12%
30-Day: -0.03%

1-Year High: $73 on 2026-02-02  
1-Year Low: $10 on 2025-04-08  
  
  
### AltRank: [---]
![AltRank Line Chart](https://lunarcrush.com/gi/w:600/t:$arwr/c:line/m:alt_rank/iv:1d.svg)  
[AltRank 24-Hour Time-Series Raw Data](/topic/$arwr/time-series/alt_rank.tsv)  
Arrowhead Research Corporation (ARWR) is currently AltRank #797 based on combined combined social and market metrics
Daily Average: [---]  
[--] Week: [---] +277  
[--] Month: [---] +117  
[--] Months: [---] +298  
[--] Year: [---] +253  
1-Year High: [-----] on 2025-06-01  
1-Year Low: [--] on 2025-03-15  
  
  
### Galaxy Score: [--]
![Galaxy Score Line Chart](https://lunarcrush.com/gi/w:600/t:$arwr/c:line/m:galaxy_score/iv:1d.svg)  
[Galaxy Score 24-Hour Time-Series Raw Data](/topic/$arwr/time-series/galaxy_score.tsv)  
Current Value: [--]  
Daily Average: [--]  
[--] Week: [--] [---]  
[--] Month: [--] [---]  
[--] Months: [--] [---]  
[--] Year: [--] [---]  
1-Year High: [--] on 2025-09-02  
1-Year Low: [--] on 2025-09-16  
  
  
### Engagements: [-----] (24h)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$arwr/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$arwr/time-series/interactions.tsv)  
Current Value: [-----]  
Daily Average: [------]  
[--] Week: [------] -70%  
[--] Month: [-------] -63%  
[--] Months: [---------] +103%  
[--] Year: [---------] +64%  
1-Year High: [-------] on 2026-01-06  
1-Year Low: [-----] on 2026-02-15  

Engagements by network (24h):
YouTube: [--]
Reddit: [--]
X: [-----]
TikTok: [--]

  
  
### Mentions: [---] (24h)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$arwr/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$arwr/time-series/posts_active.tsv)  
Current Value: [---]  
Daily Average: [---]  
[--] Week: [---] -31%  
[--] Month: [-----] -19%  
[--] Months: [-----] +88%  
[--] Year: [-----] +81%  
1-Year High: [---] on 2025-11-28  
1-Year Low: [--] on 2025-06-14  

Mentions by network (24h):
YouTube: [--]
Reddit: [--]
X: [---]
TikTok: [--]

  
  
### Creators: [--] (24h)
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$arwr/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$arwr/time-series/contributors_active.tsv)  
[--] unique social accounts have posts mentioning Arrowhead Research Corporation (ARWR) in the last [--] hours which is up 9.20% from [--] in the previous [--] hours
Daily Average: [--]  
[--] Week: [---] -28%  
[--] Month: [---] -19%  
[--] Months: [-----] +25%  
[--] Year: [-----] +63%  
1-Year High: [---] on 2025-06-28  
1-Year Low: [--] on 2025-04-28  

The most influential creators that mention Arrowhead Research Corporation in the last [--] hours

| Creator                                              | Rank | Followers | Posts | Engagements |
| -------                                              | ---- | --------- | ----- | ----------- |
| [@RNAiAnalyst](/creator/twitter/RNAiAnalyst)         | [--]    | [------]    | [--]     | [---]         |
| [@Tickeron](/creator/twitter/Tickeron)               | [--]    | [------]    | [--]    | [---]         |
| [@jonesallen99138](/creator/twitter/jonesallen99138) | [--]    | [--]        | [--]     | [---]         |
| [@NightOwlBiotech](/creator/twitter/NightOwlBiotech) | [--]    | [-----]     | [--]     | [--]          |
| [@BikeRieder](/creator/twitter/BikeRieder)           | [--]    | [-----]     | [--]     | [--]          |
| [@Hall8Jack](/creator/twitter/Hall8Jack)             | [--]    | [-----]     | [--]     | [--]          |
| [@BuyTheUgly](/creator/twitter/BuyTheUgly)           | [--]    | [--]        | [--]     | [--]          |
| [@BehaviorFin](/creator/twitter/BehaviorFin)         | [--]    | [-----]     | [--]     | [--]          |
| [@Oligo_bio](/creator/twitter/Oligo_bio)             | [--]    | [---]       | [--]     | [--]          |
| [@HedgeFundTips](/creator/twitter/HedgeFundTips)     | [--]   | [------]    | [--]     | [--]          |

[View More](/list/creators/$arwr/100)
  
  
### Sentiment: 74%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$arwr/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$arwr/time-series/sentiment.tsv)  
Current Value: 74%  
Daily Average: 76%  
[--] Week: 100% no change  
[--] Month: 91% +20%  
[--] Months: 91% +1%  
[--] Year: 91% +23%  
1-Year High: 100% on 2025-06-12  
1-Year Low: 24% on 2025-03-20  

Most Supportive Themes:
- RNAi Technology Focus: (20%) Community discussions on the strengths and potential of RNAi therapies, comparing them to other gene-editing technologies.
- Pipeline Progress & Data: (15%) Discussions highlighting promising pipeline progress and potential data releases for programs like ARO-C3 and ARO-MMP7.
- Novartis Deal: (10%) Arrowhead Pharmaceuticals' global license and collaboration agreement with Novartis for the ARO-SNCA program.
  
Most Critical Themes:
- Competitive Landscape: (10%) Frequent mentions of the competitive RNAi and broader biotech space, with comparisons to other companies.
- Valuation Concerns: (5%) Some community members question Arrowhead's current valuation compared to companies with commercialized drugs.
  
  
  
### Social Dominance: 0.00737%
![Social Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$arwr/c:line/m:social_dominance/iv:1d.svg)  
[Social Dominance 24-Hour Time-Series Raw Data](/topic/$arwr/time-series/social_dominance.tsv)  
Current Value: 0.00737%  
Daily Average: 0.021%  
[--] Week: 0.023% +0.011%  
[--] Month: 0.043% +0.022%  
[--] Months: 0.043% +0.021%  
[--] Year: 0.043% +0.0051%  
1-Year High: 0.087% on 2025-11-28  
1-Year Low: 0.0055% on 2025-06-14  
  
  
### Market Dominance: 0.01%
![Market Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$arwr/c:line/m:market_dominance/iv:1d.svg)  
[Market Dominance 24-Hour Time-Series Raw Data](/topic/$arwr/time-series/market_dominance.tsv)  
Current Value: 0.01%  
Daily Average: 0%  
1-Year High: 0.012% on 2026-02-02  
1-Year Low: 0.00206% on 2025-04-08  
  
  
### Market Cap: $8,936,854,366
![Market Cap Line Chart](https://lunarcrush.com/gi/w:600/t:$arwr/c:line/m:market_cap/iv:1d.svg)  
[Market Cap 24-Hour Time-Series Raw Data](/topic/$arwr/time-series/market_cap.tsv)  
Current Value: $8,936,854,366  
Daily Average: $4,351,469,854  
[--] Week: $8,893,444,387 -2.20%  
[--] Month: $8,936,854,366 -3.20%  
[--] Months: $8,936,854,366 +225%  
[--] Year: $8,936,854,366 +261%  
1-Year High: $10,222,349,870 on 2026-02-02  
1-Year Low: $1,240,760,298 on 2025-04-08  

### Top Arrowhead Research Corporation Social Posts
Top posts by engagements in the last [--] hours

*Showing a maximum of [--] top social posts without a LunarCrush subscription.*

"$ARWR- another I sold too soon but glad for longs. Set price alerts to revisit if comes down to my range Redemplo off to a good start progress for core cardiovascular pipeline intriguing (if unclear) early data for obesity & nice optionality in neurdegen + other tissue types $ARWR (NP) From today's trades https://t.co/cnLchnECL3 $ARWR (NP) From today's trades https://t.co/cnLchnECL3"  
[X Link](https://x.com/jfais20/status/2022074770154746322) [@jfais20](/creator/x/jfais20) 2026-02-12T22:26Z 11.5K followers, [----] engagements


"$beam $arwr the desire to rule out future liver issues could be a motivation to adopt genome editing along with the apparent lung benefit (but deep Z--M conversion needed); for #RNAi knockdown treatment only makes sense if liver disease has become apparent or somebody is at very high risk. $prme https://twitter.com/i/web/status/2022046440126615665 https://twitter.com/i/web/status/2022046440126615665"  
[X Link](https://x.com/RNAiAnalyst/status/2022046440126615665) [@RNAiAnalyst](/creator/x/RNAiAnalyst) 2026-02-12T20:33Z 21.2K followers, [----] engagements


"$alny has initiated a phase [--] of fast-follower () ALN-2232 targeting Alk-7 in fat tissue for obesity and weight mgmt as quarterly product revs reach $1B: $arwr $wve https://finance.yahoo.com/news/alnylam-pharmaceuticals-reports-fourth-quarter-130000068.html https://finance.yahoo.com/news/alnylam-pharmaceuticals-reports-fourth-quarter-130000068.html"  
[X Link](https://x.com/RNAiAnalyst/status/2021936314401042753) [@RNAiAnalyst](/creator/x/RNAiAnalyst) 2026-02-12T13:15Z 21.2K followers, [----] engagements


"#earnings after the close on Thursday February [--] [----] $AMZN $IREN $RDDT $MSTR $RBLX $BE $CLSK $AFRM $FTNT $DOCS $TEAM $MCHP $GOLD $DLR $ARW $ARWR $MPWR $BILL $BBD $G $RGA $VSAT $ILMN $MOH $GEN $HUBG $FLS $KN $BYD $CNO $COTY $BARK $MITK $MTD $NVST $PI $VTR $STEP $ATR $ASYS $COUR $CDP $LION $CUZ $EHC $EQR $STRT $SYNA $SSNC $RBBN https://www.earningswhispers.com/calendar https://www.earningswhispers.com/calendar"  
[X Link](https://x.com/eWhispers/status/2019449937860215005) [@eWhispers](/creator/x/eWhispers) 2026-02-05T16:35Z 551.6K followers, 67K engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing

Arrowhead Research Corporation (ARWR)

Arrowhead Pharmaceuticals (ARWR) stock is surging, hitting a 52-week high driven by positive FDA designations and a Novartis collaboration. Increased social media buzz and analyst price target hikes are fueling this upward momentum.

About Arrowhead Research Corporation

Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing gene-silencing medicines for intractable diseases.
Arrowhead Research Corporation uses the ticker $ARWR for trading. Listed in the Stocks category within the Healthcare sectors.

Insights

  • Arrowhead Research Corporation (ARWR) social dominance hit [------] which is 103% higher than it's daily average.
  • Arrowhead Research Corporation (ARWR) social dominance is up 210.22% from the previous [--] months.

Price: $63.80

Price Line Chart
Price 24-Hour Time-Series Raw Data
The stock price is strongly positive, reaching a 52-week high, supported by recent positive news like FDA Breakthrough Therapy Designation and a Novartis collaboration. Increased social media mentions and trading volume, along with a raised price target from Piper Sandler, are amplifying this upward momentum.

24-Hour: 1.81% 7-Day: -1.12% 30-Day: -0.03%

1-Year High: $73 on 2026-02-02
1-Year Low: $10 on 2025-04-08

AltRank: [---]

AltRank Line Chart
AltRank 24-Hour Time-Series Raw Data
Arrowhead Research Corporation (ARWR) is currently AltRank #797 based on combined combined social and market metrics Daily Average: [---]
[--] Week: [---] +277
[--] Month: [---] +117
[--] Months: [---] +298
[--] Year: [---] +253
1-Year High: [-----] on 2025-06-01
1-Year Low: [--] on 2025-03-15

Galaxy Score: [--]

Galaxy Score Line Chart
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: [--]
Daily Average: [--]
[--] Week: [--] [---]
[--] Month: [--] [---]
[--] Months: [--] [---]
[--] Year: [--] [---]
1-Year High: [--] on 2025-09-02
1-Year Low: [--] on 2025-09-16

Engagements: [-----] (24h)

Engagements Line Chart
Engagements 24-Hour Time-Series Raw Data
Current Value: [-----]
Daily Average: [------]
[--] Week: [------] -70%
[--] Month: [-------] -63%
[--] Months: [---------] +103%
[--] Year: [---------] +64%
1-Year High: [-------] on 2026-01-06
1-Year Low: [-----] on 2026-02-15

Engagements by network (24h): YouTube: [--] Reddit: [--] X: [-----] TikTok: [--]

Mentions: [---] (24h)

Mentions Line Chart
Mentions 24-Hour Time-Series Raw Data
Current Value: [---]
Daily Average: [---]
[--] Week: [---] -31%
[--] Month: [-----] -19%
[--] Months: [-----] +88%
[--] Year: [-----] +81%
1-Year High: [---] on 2025-11-28
1-Year Low: [--] on 2025-06-14

Mentions by network (24h): YouTube: [--] Reddit: [--] X: [---] TikTok: [--]

Creators: [--] (24h)

Creators Line Chart
Creators 24-Hour Time-Series Raw Data
[--] unique social accounts have posts mentioning Arrowhead Research Corporation (ARWR) in the last [--] hours which is up 9.20% from [--] in the previous [--] hours Daily Average: [--]
[--] Week: [---] -28%
[--] Month: [---] -19%
[--] Months: [-----] +25%
[--] Year: [-----] +63%
1-Year High: [---] on 2025-06-28
1-Year Low: [--] on 2025-04-28

The most influential creators that mention Arrowhead Research Corporation in the last [--] hours

Creator Rank Followers Posts Engagements
@RNAiAnalyst [--] [------] [--] [---]
@Tickeron [--] [------] [--] [---]
@jonesallen99138 [--] [--] [--] [---]
@NightOwlBiotech [--] [-----] [--] [--]
@BikeRieder [--] [-----] [--] [--]
@Hall8Jack [--] [-----] [--] [--]
@BuyTheUgly [--] [--] [--] [--]
@BehaviorFin [--] [-----] [--] [--]
@Oligo_bio [--] [---] [--] [--]
@HedgeFundTips [--] [------] [--] [--]

View More

Sentiment: 74%

Sentiment Line Chart
Sentiment 24-Hour Time-Series Raw Data
Current Value: 74%
Daily Average: 76%
[--] Week: 100% no change
[--] Month: 91% +20%
[--] Months: 91% +1%
[--] Year: 91% +23%
1-Year High: 100% on 2025-06-12
1-Year Low: 24% on 2025-03-20

Most Supportive Themes:

  • RNAi Technology Focus: (20%) Community discussions on the strengths and potential of RNAi therapies, comparing them to other gene-editing technologies.
  • Pipeline Progress & Data: (15%) Discussions highlighting promising pipeline progress and potential data releases for programs like ARO-C3 and ARO-MMP7.
  • Novartis Deal: (10%) Arrowhead Pharmaceuticals' global license and collaboration agreement with Novartis for the ARO-SNCA program.

Most Critical Themes:

  • Competitive Landscape: (10%) Frequent mentions of the competitive RNAi and broader biotech space, with comparisons to other companies.
  • Valuation Concerns: (5%) Some community members question Arrowhead's current valuation compared to companies with commercialized drugs.

Social Dominance: 0.00737%

Social Dominance Line Chart
Social Dominance 24-Hour Time-Series Raw Data
Current Value: 0.00737%
Daily Average: 0.021%
[--] Week: 0.023% +0.011%
[--] Month: 0.043% +0.022%
[--] Months: 0.043% +0.021%
[--] Year: 0.043% +0.0051%
1-Year High: 0.087% on 2025-11-28
1-Year Low: 0.0055% on 2025-06-14

Market Dominance: 0.01%

Market Dominance Line Chart
Market Dominance 24-Hour Time-Series Raw Data
Current Value: 0.01%
Daily Average: 0%
1-Year High: 0.012% on 2026-02-02
1-Year Low: 0.00206% on 2025-04-08

Market Cap: $8,936,854,366

Market Cap Line Chart
Market Cap 24-Hour Time-Series Raw Data
Current Value: $8,936,854,366
Daily Average: $4,351,469,854
[--] Week: $8,893,444,387 -2.20%
[--] Month: $8,936,854,366 -3.20%
[--] Months: $8,936,854,366 +225%
[--] Year: $8,936,854,366 +261%
1-Year High: $10,222,349,870 on 2026-02-02
1-Year Low: $1,240,760,298 on 2025-04-08

Top Arrowhead Research Corporation Social Posts

Top posts by engagements in the last [--] hours

Showing a maximum of [--] top social posts without a LunarCrush subscription.

"$ARWR- another I sold too soon but glad for longs. Set price alerts to revisit if comes down to my range Redemplo off to a good start progress for core cardiovascular pipeline intriguing (if unclear) early data for obesity & nice optionality in neurdegen + other tissue types $ARWR (NP) From today's trades https://t.co/cnLchnECL3 $ARWR (NP) From today's trades https://t.co/cnLchnECL3"
X Link @jfais20 2026-02-12T22:26Z 11.5K followers, [----] engagements

"$beam $arwr the desire to rule out future liver issues could be a motivation to adopt genome editing along with the apparent lung benefit (but deep Z--M conversion needed); for #RNAi knockdown treatment only makes sense if liver disease has become apparent or somebody is at very high risk. $prme https://twitter.com/i/web/status/2022046440126615665 https://twitter.com/i/web/status/2022046440126615665"
X Link @RNAiAnalyst 2026-02-12T20:33Z 21.2K followers, [----] engagements

"$alny has initiated a phase [--] of fast-follower () ALN-2232 targeting Alk-7 in fat tissue for obesity and weight mgmt as quarterly product revs reach $1B: $arwr $wve https://finance.yahoo.com/news/alnylam-pharmaceuticals-reports-fourth-quarter-130000068.html https://finance.yahoo.com/news/alnylam-pharmaceuticals-reports-fourth-quarter-130000068.html"
X Link @RNAiAnalyst 2026-02-12T13:15Z 21.2K followers, [----] engagements

"#earnings after the close on Thursday February [--] [----] $AMZN $IREN $RDDT $MSTR $RBLX $BE $CLSK $AFRM $FTNT $DOCS $TEAM $MCHP $GOLD $DLR $ARW $ARWR $MPWR $BILL $BBD $G $RGA $VSAT $ILMN $MOH $GEN $HUBG $FLS $KN $BYD $CNO $COTY $BARK $MITK $MTD $NVST $PI $VTR $STEP $ATR $ASYS $COUR $CDP $LION $CUZ $EHC $EQR $STRT $SYNA $SSNC $RBBN https://www.earningswhispers.com/calendar https://www.earningswhispers.com/calendar"
X Link @eWhispers 2026-02-05T16:35Z 551.6K followers, 67K engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing

Arrowhead Research Corporation (ARWR)
/topic/$arwr